Posts

Showing posts from April, 2018

The global burden of tuberculosis: results from the Global Burden of Disease Study 2015

Summary Background An understanding of the trends in tuberculosis incidence, prevalence, and mortality is crucial to tracking of the success of tuberculosis control programmes and identification of remaining challenges. We assessed trends in the fatal and non-fatal burden of tuberculosis over the past 25 years for 195 countries and territories. Methods We analysed 10 691 site-years of vital registration data, 768 site-years of verbal autopsy data, and 361 site-years of mortality surveillance data using the Cause of Death Ensemble model to estimate tuberculosis mortality rates. We analysed all available age-specific and sex-specific data sources, including annual case notifications, prevalence surveys, and estimated cause-specific mortality, to generate internally consistent estimates of incidence, prevalence, and mortality using DisMod-MR 2.1, a Bayesian meta-regression tool. We assessed how observed tuberculosis incidence, prevalence, and mortality differed from expecte...

The promising future of nano-antioxidant therapy against environmental pollutants induced-toxicities

The promising future of nano-antioxidant therapy against environmental pollutants induced-toxicities Abstract Developmental toxicity caused by exposure to a mixture of environmental pollutants has become a major health concern. Human-made chemicals, including xenoestrogens, pesticides, heavy metals, polycyclic aromatic hydrocarbons (PAHs) are major factors that increase formation of Reactive Oxygen Species (ROS) and adversely influence endogen antioxidant defense. Humans have evolved complex antioxidants systems that protect cells from prooxidant conditions. Deficiency of any these components can cause destruction in the overall antioxidant status of an individual. Antioxidants agents can be endogenous or obtained exogenously, as a part of a diet or through dietary supplements. Although oxidative damage contributes to many pathologies the use of naturally occurring, small-molecule exogenous antioxidants as therapies for these disorders has not been successful. An ideal exogenou...

Anti-Cancer Effects of Citalopram on Hepatocellular Carcinoma Cells Occur via Cytochrome C Release and the Activation of NF-kB

Anti-Cancer Effects of Citalopram on Hepatocellular Carcinoma Cells Occur via Cytochrome C Release and the Activation of NF-kB free download here ANTICANCER.PDF   (15664K) Abstract References Citations Supplementary Data Article Media Metrics Background: Evidence has been provided of the anti-proliferative activity of citalopram against some cancer cells.  Objective: The apoptotic impact of citalopram, an antidepressant, against liver hepatocellular carcinoma cell line HepG2 was investigated in relation to the oxidative pathway and nuclear factor (NF)κB activation.  Method: The cytotoxic effects of citalopram on HepG2 cells were determined by MTT assay. Reactive oxygen species (ROS) formation and cytochrome c release were measured following treatment with citalopram. Apoptosis analysis and Bax and Bcl-­2 mRNA and protein levels were also determined.  Results: The cytotoxic effects of different concentrations of citalopram on HepG2 cells were o...

Carcinogenicity of High Consumption of Meat and Lung Cancer Risk Among Non-Smokers: A Comprehensive Meta-Analysis

ABSTRACT Increasing evidence suggests that high consumption of meat is linked to lung cancer but the previous meta-analyses did not properly address the role of tobacco smoking as a potential confounder. We conducted a meta-analysis to investigate the association of lung cancer, among never smokers, with consumption of various type of meat, fish, heterocyclic amines and polycyclic aromatic hydrocarbons. We performed a systematic literature search and meta-analysis, for highest versus lowest consumption and dose-response. The results from random effects models summarized data from 14 independent observational studies and 5368 lung cancer cases. We found a statistically significant 24% increased risk of lung cancer for high consumption of red meat (Summary Relative Risk 1.24, 95% CI 1.01–1.51), based on 11 estimates, with low heterogeneity (I2 D 31%) and no indication of publication bias. No significant associations between high consumption of other types of meat, fish nor for hetero...

Prostate cancer meta-analysis of more than 140,000 men identifies 63 novel prostate cancer susceptibility loci

Abstract Currently genome-wide association studies (GWAS) and fine-mapping efforts have identified over 100 prostate cancer (PrCa) susceptibility loci, yet over two thirds of the PrCa familial relative risk (FRR) remains unexplained. Therefore, we used a custom high-density array comprised of ~533K SNPs, where ~50% provided a GWAS backbone and the remainder included top association signals from several cancer-specific meta-analyses. We combined newly genotyped data from 46,939 PrCa cases and 27,910 controls of European ancestry with previously genotyped data for 32,255 PrCa cases and 33,202 controls of European ancestry. After excluding previously reported loci, our combined meta-analysis of 79,194 PrCa cases and 61,112 controls identified 62 novel susceptibility loci associated (P<5.0x10-8) with overall PrCa, and a locus significantly associated with early-onset PrCa (age at diagnosis ≤ 55 years). Among our novel findings, we identified significant associations with four missen...

Download Validation of Alternative Methods for Toxicity Testing book

This book provides information on best practices and new thinking regarding the validation of alternative methods for toxicity testing. It covers the validation of experimental and computational methods and integrated approaches to testing and assessment. Validation strategies are discussed for methods employing the latest technologies such as tissue-on-a-chip systems, stem cells and transcriptomics, and for methods derived from pathway-based concepts in toxicology. Validation of Alternative Methods for Toxicity Testing is divided into two sections, in the first, practical insights are given on the state-of-the-art and on approaches that have resulted in successfully validated and accepted alternative methods. The second section focuses on the evolution of validation principles and practice that are necessary to ensure fit-for-purpose validation that has the greatest impact on international regulatory acceptance of alternative methods. In this context validation needs to keep pace ...